Right Upper Quadrant Pain and the Choice of First Study
A 45-year-old woman presents with 6 hours of constant right upper quadrant pain, fever of 38.6°C, and a positive Murphy sign. Laboratory results show leukocytosis (15,000/µL) and mildly elevated alkaline phosphatase. She is 18 weeks pregnant. The emergency physician orders a right upper quadrant ultrasound, which shows gallbladder wall thickening and pericholeptic fluid but is limited by body habitus and bowel gas. The surgical team wants to rule out a common bile duct stone before deciding on laparoscopic cholecystectomy. The patient asks whether the imaging will harm the baby.
1. Explain the anatomic and physiologic basis for the patient's presentation and why ultrasound was the correct first study.
Read the worked answer
The presentation is classic for acute cholecystitis: constant RUQ pain, fever, leukocytosis, and a positive Murphy sign (inspiratory arrest on palpation of the RUQ). The gallbladder lies in the RUQ under the liver; inflammation of the gallbladder wall and surrounding tissue produces the localized peritoneal signs. Mildly elevated alkaline phosphatase suggests possible biliary obstruction, raising concern for a common bile duct stone (choledocholithiasis).
Ultrasound is first-line because it is radiation-free, widely available, and highly sensitive for gallstones and gallbladder wall thickening. In pregnancy, avoiding ionizing radiation is paramount, especially in the first trimester when organogenesis occurs. Ultrasound uses high-frequency sound waves with no known fetal risk at diagnostic intensities. The limitations (body habitus, bowel gas) are real, which is why the study was incomplete for the CBD.
Physiologically, pregnancy increases gallbladder stasis and cholesterol saturation, raising the risk of gallstones, so the pretest probability is meaningful.
2. If the ultrasound is nondiagnostic for a CBD stone, what are the next imaging options and how do you weigh fetal dose?
Read the worked answer
Options for suspected choledocholithiasis in pregnancy:
- MRCP (magnetic resonance cholangiopancreatography): No ionizing radiation; excellent for CBD stones. Generally preferred when ultrasound is nondiagnostic. Gadolinium is avoided in pregnancy unless essential; non-contrast MRCP is usually sufficient.
- Endoscopic ultrasound (EUS): No ionizing radiation, high sensitivity for CBD stones, and allows therapeutic ERCP in the same session if a stone is found. Often the best next step when the pretest probability is high.
- ERCP: Diagnostic and therapeutic, but invasive; fluoroscopy is used. Fetal dose can be minimized with shielding, collimation, and limited fluoroscopy time.
- CT: Avoid unless absolutely necessary; fetal dose from a limited RUQ CT is low (typically <10 mGy) but is higher than MRCP/EUS and should be reserved for equivocal cases or suspected complications.
Weighing: The fetal risk from diagnostic radiation is small at these doses, but the ALARA principle and the availability of radiation-free alternatives favor MRCP or EUS. The decision should involve the patient, obstetrics, and surgery, and be documented.
3. How would you counsel the patient about fetal risk?
Read the worked answer
Counsel that ultrasound and MRI/MRCP do not use ionizing radiation and are considered safe in pregnancy. If fluoroscopy or CT becomes necessary, the fetal dose is typically well below the threshold (50-100 mGy) associated with deterministic effects such as malformation or intellectual disability; the main concern at diagnostic doses is a small stochastic risk that is difficult to quantify but generally considered low. Emphasize that untreated choledocholithiasis or cholecystitis poses a greater risk to mother and fetus than the diagnostic imaging. Document the discussion and the patient's questions.